Skip to main content

Abstract

The HEALing (Helping to End Addiction Long-term) Communities Study (HCS) aims to test the effectiveness of the Communities That HEAL intervention in decreasing opioid overdose deaths in 67 communities across four U.S. states. This intervention enlists a collaborative team of researchers, academic experts, and community coalitions to select and implement interventions from a menu of evidence-based practices, including medications for opioid use disorder (MOUD). The HCS’s New York team developed an integrated network systems (INS) approach with a mapping tool to coach coalitions in the selection of strategies to enhance medication treatment. With the INS approach, community coalitions develop a map of service delivery venues in their local county to better engage people with medication treatment wherever this need arises. The map is structured around core services that can provide maintenance MOUD and satellite services, which include all settings where people with opioid use disorder are encountered and can be identified, possibly given medication, and referred to core programs for ongoing MOUD care. This article describes the rationale for the INS mapping tool, with a discussion framed by the consolidated framework for implementation research, and provides a case example of its application.

Get full access to this content

View all available purchase options and get full access to this content.

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services
Psychiatric Services
Pages: 580 - 588
PubMed: 38347814

History

Received: 30 March 2023
Revision received: 15 September 2023
Revision received: 29 October 2023
Accepted: 7 November 2023
Published online: 13 February 2024
Published in print: June 01, 2024

Keywords

  1. Opioid use disorder
  2. Overdoses
  3. Public health
  4. Medications for opioid use disorder
  5. Medication-assisted treatment
  6. Implementation science

Authors

Details

Jonathan M. Wai, M.D. [email protected]
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, and Division on Substance Use Disorders, New York State Psychiatric Institute, New York City (Wai, Blevins, Campbell, Levin, Nunes); School of Social Work, Columbia University, New York City (Hunt, Gilbert, El-Bassel).
Derek Blevins, M.D.
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, and Division on Substance Use Disorders, New York State Psychiatric Institute, New York City (Wai, Blevins, Campbell, Levin, Nunes); School of Social Work, Columbia University, New York City (Hunt, Gilbert, El-Bassel).
Tim Hunt, Ph.D.
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, and Division on Substance Use Disorders, New York State Psychiatric Institute, New York City (Wai, Blevins, Campbell, Levin, Nunes); School of Social Work, Columbia University, New York City (Hunt, Gilbert, El-Bassel).
Louisa Gilbert, Ph.D.
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, and Division on Substance Use Disorders, New York State Psychiatric Institute, New York City (Wai, Blevins, Campbell, Levin, Nunes); School of Social Work, Columbia University, New York City (Hunt, Gilbert, El-Bassel).
Aimee N. C. Campbell, Ph.D.
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, and Division on Substance Use Disorders, New York State Psychiatric Institute, New York City (Wai, Blevins, Campbell, Levin, Nunes); School of Social Work, Columbia University, New York City (Hunt, Gilbert, El-Bassel).
Frances R. Levin, M.D.
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, and Division on Substance Use Disorders, New York State Psychiatric Institute, New York City (Wai, Blevins, Campbell, Levin, Nunes); School of Social Work, Columbia University, New York City (Hunt, Gilbert, El-Bassel).
Nabila El-Bassel, Ph.D.
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, and Division on Substance Use Disorders, New York State Psychiatric Institute, New York City (Wai, Blevins, Campbell, Levin, Nunes); School of Social Work, Columbia University, New York City (Hunt, Gilbert, El-Bassel).
Edward Nunes, M.D.
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, and Division on Substance Use Disorders, New York State Psychiatric Institute, New York City (Wai, Blevins, Campbell, Levin, Nunes); School of Social Work, Columbia University, New York City (Hunt, Gilbert, El-Bassel).

Notes

Send correspondence to Dr. Wai ([email protected]).

Competing Interests

Dr. Blevins has served as a consultant to Pear Therapeutics. Dr. Levin receives grant support from US WorldMeds, research support from Aelis Farma, medication from Indivior for research, and royalties from American Psychiatric Association Publishing. Dr. Levin has served as an advisory board member for Alkermes, Indivior, Novartis, Teva Pharmaceutical Industries, and US WorldMeds and is a consultant to Major League Baseball. Dr. Nunes has received medication or digital therapeutics for research from Alkermes, Braeburn, Indivior, Pear Therapeutics, and CHESS Health and has served as a consultant to Alkermes, Indivior, Pear Therapeutics, and Camurus. The other authors report no financial relationships with commercial interests.

Funding Information

This research was supported by the NIH and the Substance Abuse and Mental Health Services Administration (SAMHSA) through the NIH Helping to End Addiction Long-term (HEAL) Initiative (award UM1DA049415) and by the National Institute on Alcohol Abuse and Alcoholism (award K23AA028295).The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, SAMHSA, or the NIH HEAL Initiative.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share